Exploration of the Potential Mechanism of Yujin Powder Treating Dampness-heat Diarrhea by Integrating UPLC-MS/MS and Network Pharmacology Prediction


Cite item

Full Text

Abstract

Background:Yujin powder (YJP) is a classic prescription for treating dampness-heat diarrhea (DHD) in Traditional Chinese Medicine (TCM), but the main functional active ingredients and the exact mechanisms have not been systematically studied.

Objective:This study aimed to preliminarily explore the potential mechanisms of YJP for treating DHD by integrating UPLC-MS/MS and network pharmacology methods.

Method:Ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technology was used to determine the ingredients of YJP. And then, the targets of these components were predicted and screened from TCMSP, SwissTargetPrediction databases. The disease targets related to DHD were obtained by using the databases of GeneCards, OMIM, DisGeNET, TTD, and DrugBank. The protein-protein interaction networks (PPI) of YJP-DHD were constructed using the STRING database and Origin 2022 software to identify the cross-targets by screening the core-acting targets and a network diagram by Cytoscape 3.8.2 software was also constructed. Metascape database was used for performing GO and KEGG enrichment anlysis on the core genes. Finally, molecular docking was used to verify the results with AutoDock 4.2.6, AutoDock Tools 1.5.6, PyMOL 2.4.0, and Open Babel 2.3.2 software.

Result:597 components in YJP were detected, and 153 active components were obtained through database screening, among them the key active ingredients include coptisine, berberine, baicalein, etc. There were 362 targets treating DHD, among them the core targets included TNF, IL-6, ALB, etc. The enriched KEGG pathways mainly involve PI3K-Akt, TNF, MAPK, etc. Molecular docking results showed that coptisine, berberine, baicalein, etc., had a strong affinity with TNF, IL-6, and MAPK14. Therefore, TNF, IL-6, MAPK14, ALB, etc., are the key targets of the active ingredients of YJP coptisine, baicalein, and berberine, etc. They have the potential to regulate PI3K-Akt, MAPK, and TNF signalling pathways. The component-target-disease network diagram revealed that YJP treated DHD through the effects of anti-inflammation, anti-diarrhea, immunoregulation, and improving intestinal mucosal injury.

Conclusion:It is demonstrated that YJP treats DHD mainly through the main active ingredients coptisine, berberine, baicalein, etc. comprehensively exerting the effects of anti-inflammation, anti-diarrhea, immunoregulation, and improving intestinal mucosal injury, which will provide evidence for further in-depth studying the mechanism of YJP treating DHD.

About the authors

Li-dong Jiang

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Wang-dong Zhang

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Bao-shan Wang

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Yan-zi Cai

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Xue Qin

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Wen-bo Zhao

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Peng Ji

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Zi-wen Yuan

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Yan-ming Wei

College of Veterinary Medicine, Gansu Agricultural University

Email: info@benthamscience.net

Wan-ling Yao

College of Veterinary Medicine, Gansu Agricultural University

Author for correspondence.
Email: info@benthamscience.net

References

  1. Troeger, C.; Khalil, I.A.; Blacker, B.F.; Molly, H.B.; Robert, C.R.J. Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017. Lancet Infect. Dis., 2020, 20(1), 60-79. doi: 10.1016/S1473-3099(19)30410-4 PMID: 31678026
  2. Du, W.; Wang, X.; Xu, L.; Zhou, X.; Song, D.; Xu, Q. Editorial: Research advances in intestinal diseases and related diarrhea in animal production. Front. Vet. Sci., 2023, 10, 1201231. doi: 10.3389/fvets.2023.1201231 PMID: 37215480
  3. Xu, Y.L. Study on intestinal microbial structure and fecal metabolomics in diarrheic piglets., Master Thesis, Anhui Agricultural Universit: Anhui, June 2020.
  4. Lv, X.Y. Effect of Cornus officinalis-Cortex moutan onpiglet diarrhea caused by LT enterotoxigenic Escherichia coli., Master Thesis, Harbin University of Commerce: Harbin, June 2020.
  5. Hur, T.Y.; Jung, Y.H.; Choe, C.Y.; Cho, Y.I.; Kang, S-J.; Lee, H-J.; Ki, K-S.; Baek, K-S.; Suh, G-H. The dairy calf mortality: the causes of calf death during ten years at a large dairy farm in Korea. Daehan Suyi Haghoeji, 2013, 53(2), 103-108. doi: 10.14405/kjvr.2013.53.2.103
  6. Woldemariam, S.; Zewde, S.; Hameto, D.; Habtamu, A. Major causes of lamb mortality at Ebinat woreda, Amhara National Regional State, North-western Ethiopia. Ethiop. Vet. J., 2014, 18, 57-71.
  7. Liu, Z.J.; Xu, J.Q. Chinese veterinary medicine for animal medicine; People's medical publishing house: Bei Jing, 2002.
  8. Wang, Y.G.; Shi, S.F. Chinese veterinary medicine for animal medicine; People's medical publishing house: Bei Jing, 2020.
  9. Xiong, R.; Li, W.; Li, Y.; Zheng, K.; Zhang, T.; Gao, M.; Li, Y.; Hu, L.; Hu, C. Er Shen Wan extract reduces diarrhea and regulates AQP 4 and NHE 3 in a rat model of spleen-kidney Yang deficiency–induced diarrhea. Biomed. Pharmacother., 2018, 98, 834-846. doi: 10.1016/j.biopha.2018.01.023 PMID: 29571254
  10. Zhang, Y.; Wen, W. Treatment of equine damp-heat diarrhea with modified Jinsan and acupoint application of traditional Chinese medicine. Chin. J. Vet. Med., 2012, 48(2), 89.
  11. Ma, H.R. Modified Yujin Powder for Calf Diarrhea. Journal of Trad. Chin. Veter. Med., 2007, 26(5), 1.
  12. Fu, N.X. Study on Jiawei Yujin Powder in the treatment of Bovine Acute Enteritis. Agricultural Technical Services., 2015, 32(11), 1.
  13. Yuan, H.; Ma, Q.; Cui, H.; Liu, G.; Zhao, X.; Li, W.; Piao, G. How can synergism of traditional medicines benefit from network pharmacology? Molecules, 2017, 22(7), 1135. doi: 10.3390/molecules22071135 PMID: 28686181
  14. Azeem, M.; Jamil, M.K.; Shang, Y. Notes on the localization of generalized hexagonal cellular networks. Mathematics, 2023, 11(4), 844. doi: 10.3390/math11040844
  15. Villoutreix, B.; Bastard, K.; Sperandio, O.; Fahraeus, R.; Poyet, J.L.; Calvo, F.; Déprez, B.; Miteva, M. In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeutics. Curr. Pharm. Biotechnol., 2008, 9(2), 103-122. doi: 10.2174/138920108783955218 PMID: 18393867
  16. Xue, L.C.; Dobbs, D.; Bonvin, A.M.J.J.; Honavar, V. Computational prediction of protein interfaces: A review of data driven methods. FEBS Lett., 2015, 589(23), 3516-3526. doi: 10.1016/j.febslet.2015.10.003 PMID: 26460190
  17. Laali, K.K.; Greves, W.J.; Correa-Smits, S.J.; Zwarycz, A.T.; Bunge, S.D.; Borosky, G.L.; Manna, A.; Paulus, A.; Chanan-Khan, A. Novel fluorinated curcuminoids and their pyrazole and isoxazole derivatives: Synthesis, structural studies, Computational/Docking and in-vitro bioassay. J. Fluor. Chem., 2018, 206, 82-98. doi: 10.1016/j.jfluchem.2017.11.013
  18. Ru, J.; Li, P.; Wang, J.; Zhou, W.; Li, B.; Huang, C.; Li, P.; Guo, Z.; Tao, W.; Yang, Y.; Xu, X.; Li, Y.; Wang, Y.; Yang, L. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform., 2014, 6(1), 13. doi: 10.1186/1758-2946-6-13 PMID: 24735618
  19. Daina, A.; Michielin, O.; Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res., 2019, 47(W1), W357-W364. doi: 10.1093/nar/gkz382 PMID: 31106366
  20. Stelzer, G.; Rosen, N.; Plaschkes, I.; Zimmerman, S.; Twik, M.; Fishilevich, S.; Stein, T.I.; Nudel, R.; Lieder, I.; Mazor, Y.; Kaplan, S.; Dahary, D.; Warshawsky, D.; Guan-Golan, Y.; Kohn, A.; Rappaport, N.; Safran, M.; Lancet, D. The genecards suite: From gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinformatics, 2016, 54, 1.30.1-1.30.33. doi: 10.1002/cpbi.5
  21. Hamosh, A.; Amberger, J.S.; Bocchini, C.; Scott, A.F.; Rasmussen, S.A. Online Mendelian Inheritance in Man (OMIM ®): Victor MCKUSICK 's magnum opus. Am. J. Med. Genet. A., 2021, 185(11), 3259-3265. doi: 10.1002/ajmg.a.62407 PMID: 34169650
  22. Piñero, J.; Ramírez-Anguita, J.M.; Saüch-Pitarch, J.; Ronzano, F.; Centeno, E.; Sanz, F.; Furlong, L.I. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res., 2020, 48(D1), D845-D855. PMID: 31680165
  23. Zhou, Y.; Zhang, Y.; Lian, X.; Li, F.; Wang, C.; Zhu, F.; Qiu, Y.; Chen, Y. Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Res., 2022, 50(D1), D1398-D1407. doi: 10.1093/nar/gkab953 PMID: 34718717
  24. Wishart, D.S.; Feunang, Y.D.; Guo, A.C.; Lo, E.J.; Marcu, A.; Grant, J.R.; Sajed, T.; Johnson, D.; Li, C.; Sayeeda, Z.; Assempour, N.; Iynkkaran, I.; Liu, Y.; Maciejewski, A.; Gale, N.; Wilson, A.; Chin, L.; Cummings, R.; Le, D.; Pon, A.; Knox, C.; Wilson, M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res., 2018, 46(D1), D1074-D1082. doi: 10.1093/nar/gkx1037 PMID: 29126136
  25. Yao, W.; Yang, C.; Wen, Y.; Zhang, W.; Zhang, X.; Ma, Q.; Ji, P.; Hua, Y.; Wei, Y. Treatment effects and mechanisms of Yujin Powder on rat model of large intestine dampness-heat syndrome. J. Ethnopharmacol., 2017, 202, 265-280. doi: 10.1016/j.jep.2017.03.030 PMID: 28330724
  26. Zhou, Y.X.; Gong, X.H.; Zhang, H.; Peng, C. A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects. Biomed. Pharmacother., 2020, 130, 110505. doi: 10.1016/j.biopha.2020.110505 PMID: 32682112
  27. Gu, P.; Zhu, L.; Liu, Y.; Zhang, L.; Liu, J.; Shen, H. Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice. Int. Immunopharmacol., 2017, 50, 152-160. doi: 10.1016/j.intimp.2017.06.022 PMID: 28666238
  28. Wang, Y.; Liu, J.; Huang, Z.; Li, Y.; Liang, Y.; Luo, C.; Ni, C.; Xie, J.; Su, Z.; Chen, J.; Li, C. Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response. Eur. J. Pharmacol., 2021, 896, 173912. doi: 10.1016/j.ejphar.2021.173912 PMID: 33508280
  29. Li, C.; Xi, Y.; Li, S.; Zhao, Q.; Cheng, W.; Wang, Z.; Zhong, J.; Niu, X.; Chen, G. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation. Mol. Immunol., 2015, 67(2)(2 Pt B), 444-454. doi: 10.1016/j.molimm.2015.07.013 PMID: 26224047
  30. Zhu, L.; Gu, P.; Shen, H. Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats. Int. Immunopharmacol., 2019, 68, 242-251. doi: 10.1016/j.intimp.2018.12.036 PMID: 30743078
  31. Yao, J. Zhao, L.; Zhao, Q.; Zhao, Y.; Sun, Y.; Zhang, Y.; Miao, H.; You, Q-D.; Hu, R.; Guo, Q-L. NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis. Cell Death Dis., 2014, 5(6), e1283. doi: 10.1038/cddis.2014.221 PMID: 24901054
  32. Ding, K. Tan, Y.Y.; Ding, Y.; Fang, Y.; Yang, X.; Fang, J.; Xu, D.C.; Zhang, H.; Lu, W.; Li, M.; Huang, S.C.; Cai, M.L.; Song, Y.; Ding, Y.J.; Zhang, S.M. β‐Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria. J. Cell. Biochem., 2019, 120(4), 5687-5694. doi: 10.1002/jcb.27853 PMID: 30548286
  33. Sayar, S.; Kurbuz, K.; Kahraman, R.; Caliskan, Z.; Atalay, R.; Ozturk, O.; Doganay, H.L.; Ozdil, K. A practical marker to determining acute severe ulcerative colitis: CRP/albumin ratio. North. Clin. Istanb., 2019, 7(1), 49-55. PMID: 32232203
  34. Tanriverdi, Z.; Gungoren, F.; Tascanov, M.B.; Besli, F.; Altiparmak, I.H. Comparing the diagnostic value of the C-reactive protein to albumin ratio with other inflammatory markers in patients with stable angina pectoris. Angiology, 2020, 71(4), 360-365. doi: 10.1177/0003319719897490 PMID: 31888345
  35. Lai, Y.T. Perificam in combination with mesalazine for patients with mild to moderate ulcerative colitis Clinical efficacy and its influence on CRP and ESR levels. Anti Infect Pharm, 2019, 16(2), 332-334.
  36. Qin, G.; Tu, J.; Liu, L.; Luo, L.; Wu, J.; Tao, L.; Zhang, C.; Geng, X.; Chen, X.; Ai, X.; Shen, B.; Pan, W. Serum albumin and C-reactive protein/albumin ratio are useful biomarkers of Crohn’s disease activity. Med. Sci. Monit., 2016, 22, 4393-4400. doi: 10.12659/MSM.897460 PMID: 27848931
  37. Huang, J.B. Effect and Mechanisms of Huangqin Decoction Combined withRadix Actinidiae Chinensison Colorectal Cancer Mice withDamp-heat Ftagnation Syndrome., PhD Thesis, Zhejiang Chinese Medical University: Zhejiang, June 2022.
  38. Dey, N.; De, P.; Leyland-Jones, B. PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials. Pharmacol. Ther., 2017, 175, 91-106. doi: 10.1016/j.pharmthera.2017.02.037 PMID: 28216025
  39. Liu, H.Q.; An, Y.W.; Hu, A.Z.; Li, M.H.; Wu, J.L.; Liu, L.; Shi, Y.; Cui, G.H.; Chen, Y. Critical roles of the PI3K-Akt-mTOR signaling pathway in apoptosis and autophagy of astrocytes induced by methamphetamine. Open Chem., 2019, 17(1), 96-104. doi: 10.1515/chem-2019-0015
  40. Schuster, A.T.; Homer, C.R.; Kemp, J.R.; Nickerson, K.P.; Deutschman, E.; Kim, Y.; West, G.; Sadler, T.; Stylianou, E.; Krokowski, D.; Hatzoglou, M.; de la Motte, C.; Rubin, B.P.; Fiocchi, C.; McDonald, C.; Longworth, M.S. Chromosome-associated protein D3 promotes bacterial clearance in human intestinal epithelial cells by repressing expression of amino acid transporters. Gastroenterology, 2015, 148(7), 1405-1416.e3. doi: 10.1053/j.gastro.2015.02.013 PMID: 25701737
  41. Zhu, L.; Shen, H.; Gu, P.Q.; Liu, Y.J.; Zhang, L.; Cheng, J.F. Baicalin alleviates TNBS induced colitis by inhibiting PI3K/AKT pathway activation. Exp. Ther. Med., 2020, 20(1), 581-590. doi: 10.3892/etm.2020.8718 PMID: 32537016
  42. Li, C.; Wang, W. Molecular biology of aquaporins. Adv. Exp. Med. Biol., 2017, 969, 1-34. doi: 10.1007/978-94-024-1057-0_1 PMID: 28258563
  43. Nishimura, H.; Yang, Y. Aquaporins in avian kidneys: function and perspectives. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2013, 305(11), R1201-R1214. doi: 10.1152/ajpregu.00177.2013 PMID: 24068044
  44. Liao, S.; Gan, L.; Lv, L.; Mei, Z. The regulatory roles of aquaporins in the digestive system. Genes Dis., 2021, 8(3), 250-258. doi: 10.1016/j.gendis.2019.12.011 PMID: 33997172
  45. Ikarashi, N.; Kon, R.; Sugiyama, K. Aquaporins in the colon as a new therapeutic target in diarrhea and constipation. Int. J. Mol. Sci., 2016, 17(7), 1172. doi: 10.3390/ijms17071172 PMID: 27447626
  46. Liu, C.; Zheng, Y.; Xu, W.; Wang, H.; Lin, N. Rhubarb tannins extract inhibits the expression of aquaporins 2 and 3 in magnesium sulphate-induced diarrhoea model. BioMed Res. Int., 2014, 2014(3), 1-14. doi: 10.1155/2014/619465 PMID: 25215286
  47. Feng, Y.J.; Li, Y.Y. The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease. J. Dig. Dis., 2011, 12(5), 327-332. doi: 10.1111/j.1751-2980.2011.00525.x PMID: 21955425
  48. Chen, Y.; Lu, S.; Zhang, Y.; Yu, J.; Deng, L.; Chen, H.; Zhang, Y.; Zhou, N.; Yuan, K.; Yu, L.; Xiong, Z.; Gui, X.; Yu, Y.; Min, W. TLR2 agonist Pam3CSK4 enhances the antibacterial functions of GM-CSF induced neutrophils to methicillin-resistant Staphylococcus aureus. Microb. Pathog., 2019, 130, 204-212. doi: 10.1016/j.micpath.2019.02.030 PMID: 30885749
  49. Lee, I.A.; Hyun, Y.J.; Kim, D.H. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation. Eur. J. Pharmacol., 2010, 648(1-3), 162-170. doi: 10.1016/j.ejphar.2010.08.046 PMID: 20828550
  50. Liu, Y.; Liu, X.; Hua, W.; Wei, Q.; Fang, X.; Zhao, Z.; Ge, C.; Liu, C.; Chen, C.; Tao, Y.; Zhu, Y. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis. Int. Immunopharmacol., 2018, 57, 121-131. doi: 10.1016/j.intimp.2018.01.049 PMID: 29482156
  51. Lin, C.K.; Lin, Y.H.; Huang, T.C.; Shi, C.S.; Yang, C.T.; Yang, Y.L. VEGF mediates fat embolism-induced acute lung injury via VEGF receptor 2 and the MAPK cascade. Sci. Rep., 2019, 9(1), 11713. doi: 10.1038/s41598-019-47276-4 PMID: 31406128
  52. Shibuya, H.; Hirohata, S. Differential effects of IFN-α on the expression of various TH2 cytokines in human CD4+ T cells. J. Allergy Clin. Immunol., 2005, 116(1), 205-212. doi: 10.1016/j.jaci.2005.03.016 PMID: 15990796

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers